Incyte Corp. (INCY)
115.96
-0.97
(-0.83%)
USD |
NASDAQ |
Oct 23, 15:56
Incyte Market Cap : 23.31B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 22, 2026 | 23.50B |
| October 21, 2026 | 22.80B |
| October 20, 2026 | 23.44B |
| October 19, 2026 | 22.76B |
| October 16, 2026 | 22.72B |
| October 15, 2026 | 22.76B |
| October 14, 2026 | 22.42B |
| October 13, 2026 | 21.83B |
| October 12, 2026 | 22.38B |
| October 09, 2026 | 22.67B |
| October 08, 2026 | 22.66B |
| October 07, 2026 | 22.80B |
| October 06, 2026 | 22.66B |
| October 05, 2026 | 22.94B |
| October 02, 2026 | 23.17B |
| October 01, 2026 | 23.54B |
| September 30, 2026 | 24.39B |
| September 29, 2026 | 24.76B |
| September 28, 2026 | 25.09B |
| September 25, 2026 | 24.90B |
| September 24, 2026 | 25.01B |
| September 23, 2026 | 25.05B |
| September 22, 2026 | 25.51B |
| September 21, 2026 | 25.05B |
| September 18, 2026 | 25.18B |
| Date | Value |
|---|---|
| September 17, 2026 | 25.65B |
| September 16, 2026 | 25.07B |
| September 15, 2026 | 24.47B |
| September 14, 2026 | 24.56B |
| September 11, 2026 | 24.41B |
| September 10, 2026 | 24.78B |
| September 09, 2026 | 25.33B |
| September 08, 2026 | 25.00B |
| September 04, 2026 | 25.47B |
| September 03, 2026 | 25.73B |
| September 02, 2026 | 25.89B |
| September 01, 2026 | 25.12B |
| August 31, 2026 | 24.76B |
| August 28, 2026 | 25.00B |
| August 27, 2026 | 25.67B |
| August 26, 2026 | 25.75B |
| August 25, 2026 | 26.07B |
| August 24, 2026 | 25.72B |
| August 21, 2026 | 25.69B |
| August 20, 2026 | 25.57B |
| August 19, 2026 | 25.82B |
| August 18, 2026 | 24.81B |
| August 17, 2026 | 24.82B |
| August 14, 2026 | 24.15B |
| August 13, 2026 | 24.22B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Mirum Pharmaceuticals, Inc. | 5.217B |
| Regeneron Pharmaceuticals, Inc. | 83.28B |
| AbbVie, Inc. | 505.24B |
| Alnylam Pharmaceuticals, Inc. | 30.05B |
| Biogen, Inc. | 37.06B |
Market Cap Related Metrics
| PE Ratio | 14.78 |
| PS Ratio | 4.091 |
| PEG Ratio | 0.1885 |
| Price to Book Value | 3.673 |
| Price to Free Cash Flow | 12.59 |
| Price | 115.96 |
| Earnings Yield | 6.77% |
| PEGY Ratio | 0.1885 |
| Operating PE Ratio | 12.94 |
| Normalized PE Ratio | 14.55 |